RNPEX
Price
$57.28
Change
+$1.01 (+1.79%)
Updated
Apr 11 closing price
Net Assets
129.28B
SCGVX
Price
$27.33
Change
+$0.44 (+1.64%)
Updated
Apr 11 closing price
Net Assets
1.04B
Ad is loading...

RNPEX vs SCGVX

Header iconRNPEX vs SCGVX Comparison
Open Charts RNPEX vs SCGVXBanner chart's image
American Funds New Perspective R4
Price$57.28
Change+$1.01 (+1.79%)
VolumeN/A
Net Assets129.28B
Sands Capital Global Growth I
Price$27.33
Change+$0.44 (+1.64%)
VolumeN/A
Net Assets1.04B
RNPEX vs SCGVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNPEX vs. SCGVX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNPEX is a Hold and SCGVX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 129B vs. SCGVX (1.04B). RNPEX pays higher dividends than SCGVX: RNPEX (0.56) vs SCGVX (0.00). RNPEX was incepted earlier than SCGVX: RNPEX (23 years) vs SCGVX (15 years). SCGVX (1.22) is less costly to investors than RNPEX (0.76). RNPEX is a more actively managed with annual turnover of: 24.00 vs. SCGVX (17.00). RNPEX has a lower initial minimum investment than SCGVX: RNPEX (250) vs SCGVX (100000). RNPEX annual gain was more profitable for investors over the last year : -2.75 vs. SCGVX (-12.41). RNPEX return over 5 years is better than : 45.33 vs. SCGVX (12.23).
RNPEXSCGVXRNPEX / SCGVX
Total Expense Ratio0.761.2262%
Annual Report Gross Expense Ratio0.761.2262%
Fund Existence23 years15 years-
Gain YTD-5.960-8.13173%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets129B1.04B12,464%
Annual Yield % from dividends0.560.00-
Returns for 1 year-2.75-12.4122%
Returns for 3 years3.50-4.71-74%
Returns for 5 years45.3312.23371%
Returns for 10 years52.0146.39112%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNSP1.340.16
+13.56%
CNS Pharmaceuticals Inc.
KALV11.490.95
+9.01%
KalVista Pharmaceuticals
DCTH10.660.13
+1.23%
Delcath Systems
FMS23.980.16
+0.67%
Fresenius Medical Care AG
CNMD51.73-0.56
-1.07%
CONMED Corp